Roderick MacKinnon

Last updated
Roderick MacKinnon
Roderick MacKinnon, M.D. (cropped).jpg
MacKinnon in 2014
Born (1956-02-19) February 19, 1956 (age 68)
NationalityAmerican
Alma mater
Known forPotassium Channel Structure
Spouse Jue Chen (2017–)
Awards
Scientific career
Fields Chemistry
Institutions

Roderick MacKinnon (born February 19, 1956 [1] ) is an American biophysicist, neuroscientist, and businessman. He is a professor of molecular neurobiology and biophysics at Rockefeller University who won the Nobel Prize in Chemistry together with Peter Agre in 2003 for his work on the structure and operation of ion channels. [2] [3] [4]

Contents

Biography

Early life and education

MacKinnon was born in Burlington, Massachusetts and initially attended the University of Massachusetts Boston. MacKinnon then transferred to Brandeis University after one year, and there he received a bachelor's degree in biochemistry in 1978, studying calcium transport through the cell membrane for his honors thesis in Christopher Miller's laboratory. It was also at Brandeis where MacKinnon met his future wife and working-colleague Alice Lee. [5]

After receiving his bachelor's degree from Brandeis University, MacKinnon entered medical school at Tufts University. [4] He got his M.D. in 1982 and received training in Internal Medicine at Beth Israel Hospital in Boston. He did not feel satisfied enough with the medical profession, so in 1986 he returned to Christopher Miller's laboratory at Brandeis for postdoctoral studies. [5]

Career

In 1989 he was appointed assistant professor at Harvard University [6] [7] where he studied the interaction of the potassium channel with a specific toxin derived from scorpion venom, acquainting himself with methods of protein purification and X-ray crystallography. In 1996 he moved to Rockefeller University as a professor and head of the Laboratory of Molecular Neurobiology and Biophysics where he started to work on the structure of the potassium channel. These channels are of particular importance to the nervous system and the heart and enable potassium ions to cross the cell membrane.

Scientific contributions

Potassium channels demonstrate a seemingly counterintuitive activity: they permit the passage of potassium ions, whereas they do not allow the passage of the much smaller sodium ions. Before MacKinnon's work, the detailed molecular architecture of potassium channels and the exact means by which they conduct ions remained speculative.

In 1998, despite barriers to the structural study of integral membrane proteins that had thwarted most attempts for decades, MacKinnon and colleagues determined the three-dimensional molecular structure of a potassium channel from an actinobacterium, Streptomyces lividans, utilizing X-ray crystallography. With this structure and other biochemical experiments, MacKinnon and colleagues were able to explain the exact mechanism by which potassium channel selectivity occurs. [8] [9]

His prize-winning research was conducted primarily at the Cornell High Energy Synchrotron Source (CHESS) of Cornell University, and at the National Synchrotron Light Source (NSLS) of Brookhaven National Laboratory. [10]

MacKinnon was elected to the American Philosophical Society in 2005. [11] In 2007 he became a foreign member of the Royal Netherlands Academy of Arts and Sciences. [12]

Awards and recognition

Business activities

MacKinnon is co-inventor with his friend and scientific collaborator, neurobiologist Bruce Bean of Harvard Medical School, of a dietary supplement for treating and preventing muscle cramps; they tested it in clinical trials and are co-founders a company to commercialize their invention, Flex Pharma. [14] Christoph Westphal and Jennifer Cermak were co-founders as well. [15] The company undertook drug development of a formulation of supplement as a drug candidate for neuromuscular disorders like ALS, and raised a $40 million Series A round. [15] [16] The company had an $86 million initial public offering in 2015. [17] In 2016, the company launched "HotShot" as a dietary supplement for endurance athletes. [18] In June 2018 the company halted clinical development of the drug candidate due to tolerability issues, cut its workforce, and said it was considering its strategy. [19] [20] In July 2018 MacKinnon resigned from the board of directors. [21]

Related Research Articles

<span class="mw-page-title-main">Ion channel</span> Pore-forming membrane protein

Ion channels are pore-forming membrane proteins that allow ions to pass through the channel pore. Their functions include establishing a resting membrane potential, shaping action potentials and other electrical signals by gating the flow of ions across the cell membrane, controlling the flow of ions across secretory and epithelial cells, and regulating cell volume. Ion channels are present in the membranes of all cells. Ion channels are one of the two classes of ionophoric proteins, the other being ion transporters.

<span class="mw-page-title-main">Brookhaven National Laboratory</span> United States Department of Energy national laboratory

Brookhaven National Laboratory (BNL) is a United States Department of Energy national laboratory located in Upton, New York, a hamlet of the Town of Brookhaven. It was formally established in 1947 at the site of Camp Upton, a former U.S. Army base on Long Island. Located approximately 60 miles east of New York City, it is managed by Stony Brook University and Battelle Memorial Institute.

<span class="mw-page-title-main">Alan Hodgkin</span> English physiologist and biophysicist

Sir Alan Lloyd Hodgkin was an English physiologist and biophysicist who shared the 1963 Nobel Prize in Physiology or Medicine with Andrew Huxley and John Eccles.

<span class="mw-page-title-main">Jens Christian Skou</span> Danish chemist (1918–2018)

Jens Christian Skou was a Danish biochemist and Nobel laureate.

<span class="mw-page-title-main">Rockefeller University</span> Biomedical research university in New York City, US

The Rockefeller University is a private biomedical research and graduate-only university in New York City, New York. It focuses primarily on the biological and medical sciences and provides doctoral and postdoctoral education. It is classified as a "Special Focus – Research Institution". Rockefeller is the oldest biomedical research institute in the United States.

<span class="mw-page-title-main">Potassium channel</span> Ion channel that selectively passes K+

Potassium channels are the most widely distributed type of ion channel found in virtually all organisms. They form potassium-selective pores that span cell membranes. Potassium channels are found in most cell types and control a wide variety of cell functions.

<span class="mw-page-title-main">Peter Agre</span> American physician (born 1949)

Peter Agre is an American physician, Nobel Laureate, and molecular biologist, Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and director of the Johns Hopkins Malaria Research Institute. In 2003, Agre and Roderick MacKinnon shared the 2003 Nobel Prize in Chemistry for "discoveries concerning channels in cell membranes." Agre was recognized for his discovery of aquaporin water channels. Aquaporins are water-channel proteins that move water molecules through the cell membrane. In 2009, Agre was elected president of the American Association for the Advancement of Science (AAAS) and became active in science diplomacy.

<span class="mw-page-title-main">Voltage-gated ion channel</span> Type of ion channel transmembrane protein

Voltage-gated ion channels are a class of transmembrane proteins that form ion channels that are activated by changes in a cell's electrical membrane potential near the channel. The membrane potential alters the conformation of the channel proteins, regulating their opening and closing. Cell membranes are generally impermeable to ions, thus they must diffuse through the membrane through transmembrane protein channels.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

<span class="mw-page-title-main">Cornell Laboratory for Accelerator-based Sciences and Education</span> Research institute at Cornell University in Ithaca, NY

The Cornell Laboratory for Accelerator-based ScienceS and Education (CLASSE) is a particle accelerator facility located in Wilson Laboratory on the Cornell University campus in Ithaca, New York. CLASSE was formed by merging the Cornell High-Energy Synchrotron Source (CHESS) and the Laboratory for Elementary-Particle Physics (LEPP) in July 2006. Nigel Lockyer is the Director of CLASSE in spring of 2023.

Clay Margrave Armstrong is an American physiologist and a former student of Andrew Fielding Huxley. Armstrong received his MD from Washington University School of Medicine in 1960. He is currently emeritus professor of physiology at the University of Pennsylvania. He has also held professorial appointments at Duke University and the University of Rochester.

Bertil Hille is an Emeritus Professor, and the Wayne E. Crill Endowed Professor in the Department of Physiology and Biophysics at the University of Washington. He is particularly well known for his pioneering research on cell signalling by ion channels. His book Ion Channels of Excitable Membranes has been the standard work on the subject, appearing in multiple editions since its first publication in 1984.

<span class="mw-page-title-main">Two-pore-domain potassium channel</span> Class of transport proteins

The two-pore-domain or tandem pore domain potassium channels are a family of 15 members that form what is known as leak channels which possess Goldman-Hodgkin-Katz (open) rectification. These channels are regulated by several mechanisms including signaling lipids, oxygen tension, pH, mechanical stretch, and G-proteins. Two-pore-domain potassium channels correspond structurally to a inward-rectifier potassium channel α-subunits. Each inward-rectifier potassium channel α-subunit is composed of two transmembrane α-helices, a pore helix and a potassium ion selectivity filter sequence and assembles into a tetramer forming the complete channel. The two-pore domain potassium channels instead are dimers where each subunit is essentially two α-subunits joined together.

Kaliotoxin (KTX) inhibits potassium flux through the Kv1.3 voltage-gated potassium channel and calcium-activated potassium channels by physically blocking the channel-entrance and inducing a conformational change in the K+-selectivity filter of the channel.

The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee's significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.

The channelome, sometimes called the "ion channelome", is the complete set of ion channels and porins expressed in a biological tissue or organism. It is analogous to the genome, the metabolome, the proteome, and the microbiome. Characterization of the ion channelome, referred to as channelomics, is a branch of physiology, biophysics, neuroscience, and pharmacology, with particular attention paid to gene expression. It can be performed by a variety of techniques, including patch clamp electrophysiology, PCR, and immunohistochemistry. Channelomics is being used to screen and discover new medicines.

<span class="mw-page-title-main">Lq2</span>

Lq2 is a component of the venom of the scorpion Leiurus quinquestriatus. It blocks various potassium channels, among others the inward-rectifier potassium ion channel ROMK1.

Christoph Westphal is an American biomedical businessman.

<span class="mw-page-title-main">KcsA potassium channel</span> Prokaryotic potassium ion channel

KcsA (K channel of streptomyces A) is a prokaryotic potassium channel from the soil bacterium Streptomyces lividans that has been studied extensively in ion channel research. The pH activated protein possesses two transmembrane segments and a highly selective pore region, responsible for the gating and shuttling of K+ ions out of the cell. The amino acid sequence found in the selectivity filter of KcsA is highly conserved among both prokaryotic and eukaryotic K+ voltage channels; as a result, research on KcsA has provided important structural and mechanistic insight on the molecular basis for K+ ion selection and conduction. As one of the most studied ion channels to this day, KcsA is a template for research on K+ channel function and its elucidated structure underlies computational modeling of channel dynamics for both prokaryotic and eukaryotic species.

The Perl-UNC Prize is awarded internationally in the field of neuroscience. Its purpose is two-fold: to recognize researchers for outstanding discoveries and seminal insights in neuroscience and to celebrate the strength of the neuroscience research program at the University of North Carolina at Chapel Hill.

References

  1. 1 2 3 4 5 6 7 "Roderick MacKinnon – pioneer in ion channels in cell membranes". worldofchemicals.com. 2013-02-19. Retrieved 2020-08-06.
  2. "2003 Nobel Prize in Chemistry Awarded to Researcher Roderick MacKinnon". Brookhaven National Labs. October 8, 2003. Retrieved 11 February 2010.
  3. "Nobel Prize honors Rockefeller University scientist Roderick MacKinnon for revealing process of electrical signaling in humans and other living organisms". The Rockefeller University. October 8, 2003. Retrieved 20 April 2018.
  4. 1 2 Birmingham K (June 2001). "Rod MacKinnon". Nat. Med. 7 (6): 648. doi: 10.1038/89005 . PMID   11385491. S2CID   21231263.
  5. 1 2 MacKinnon, Roderick (October 2003). Tore Frängsmyr (ed.). The Nobel Prizes 2003. Stockholm, Sweden: Nobel Foundation. Retrieved 11 February 2010.
  6. "The Nobel Prize in Chemistry 2003". NobelPrize.org. Retrieved 2020-08-04.
  7. "Laureate – Roderick MacKinnon". Lindau Nobel Mediatheque. Retrieved 2020-08-04.
  8. MacKinnon R, Cohen SL, Kuo A, Lee A, Chait BT (April 1998). "Structural conservation in prokaryotic and eukaryotic potassium channels". Science. 280 (5360): 106–9. Bibcode:1998Sci...280..106M. doi:10.1126/science.280.5360.106. PMID   9525854.
  9. Doyle DA, Morais Cabral J, Pfuetzner RA, et al. (April 1998). "The structure of the potassium channel: molecular basis of K+ conduction and selectivity". Science. 280 (5360): 69–77. Bibcode:1998Sci...280...69D. doi:10.1126/science.280.5360.69. PMID   9525859.
  10. "The Chemistry of the Cell". Brookhaven National Lab. Retrieved 13 March 2010.
  11. "APS Member History". search.amphilsoc.org. Retrieved 2021-05-28.
  12. "R. MacKinnon". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 13 February 2016. Retrieved 13 February 2016.
  13. "Function and structure of ion channels". Lasker Foundation. Albert and Mary Lasker Foundation. Retrieved 5 November 2021.
  14. "A Scientific Solution to (Finally) Stop Muscle Cramps". Outside. 1 September 2015. Retrieved 20 July 2016.
  15. 1 2 Fidler, Ben (9 September 2014). "To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M". Xconomy.
  16. Carroll, John (September 8, 2014). "Christoph Westphal launches another biotech, with the help of some wealthy friends". FierceBiotech.
  17. Garde, Damian (28 January 2015). "Flex Pharma pulls off an $86M IPO for its cramp-treating spice cocktail". Fierce Biotech. Retrieved 20 July 2016.
  18. "Fuel Buzz: New HotShot Drink Aimed at Preventing Cramps". Competitor. 2 June 2016. Retrieved 20 July 2016.
  19. Al Idrus, Amirah (June 13, 2018). "Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive". FierceBiotech.
  20. "10Q Quarterly Report". www.sec.gov. Flex via SEC Edgar. 1 August 2018.
  21. "Form 8K". Flex via SEC Edgar. 25 July 2018.